A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...

Sanofi's antibody riliprubart has received orphan drug designation from Japan's MHLW for its potential to treat CIDP.

ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and prevention of certain ...

Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.

The intravenous immunoglobulin (IVIG) market is experiencing significant growth due to the rising prevalence of autoimmune diseases, immune deficiencies, and neurological disorders.

Intravenous Immunoglobulin Likely More Effective Than Corticosteroids in Chronic Inflammatory Demyelinating Polyneuropathy. S. Andrew Josephson, MD. Disclosures. AccessMedicine from McGraw-Hill .

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

The province's Chief Public Health Office has identified between four and eight infants who require medication to protect ...